Listed

CEL Sci Corp

CVMNYSECIK 725363HealthcareFiscal year ends Sep 30

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$5.6m, Q3 FY2026
Net income−$5.7m, Q3 FY2026
CEL Sci Corp, income statement, quarterly
Line itemUnitQ4 FY20232023-09-30Q1 FY20242023-12-31Q2 FY20242024-03-31Q3 FY20242024-06-30Q4 FY20242024-09-30Q1 FY20252024-12-31Q2 FY20252025-03-31Q3 FY20252025-06-30Q4 FY20252025-09-30Q1 FY20262025-12-31Q2 FY20262026-03-31Q3 FY20262026-06-30
Revenue$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$k5,268Research and development, Q4 FY2023, three months to 2023-09-30$5.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-01-13, accession 0001654954-25-000288. Derived: 12-month figure less the 9-month figure.Report this figure4,353Research and development, Q1 FY2024, three months to 2023-12-31$4.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-02-14, accession 0001654954-25-001578.Report this figure4,629Research and development, Q2 FY2024, three months to 2024-03-31$4.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-14, accession 0001654954-25-005606.Report this figure4,703Research and development, Q3 FY2024, three months to 2024-06-30$4.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0001654954-25-009568.Report this figure4,477Research and development, Q4 FY2024, three months to 2024-09-30$4.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-12-29, accession 0001654954-25-014303. Derived: 12-month figure less the 9-month figure.Report this figure4,430Research and development, Q1 FY2025, three months to 2024-12-31$4.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-17, accession 0001654954-26-001319.Report this figure4,014Research and development, Q2 FY2025, three months to 2025-03-31$4.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001654954-26-005005.Report this figure3,740Research and development, Q3 FY2025, three months to 2025-06-30$3.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-14, accession 0001654954-26-007657.Report this figure3,703Research and development, Q4 FY2025, three months to 2025-09-30$3.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-12-29, accession 0001654954-25-014303. Derived: 12-month figure less the 9-month figure.Report this figure3,677Research and development, Q1 FY2026, three months to 2025-12-31$3.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-17, accession 0001654954-26-001319.Report this figure3,767Research and development, Q2 FY2026, three months to 2026-03-31$3.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001654954-26-005005.Report this figure3,650Research and development, Q3 FY2026, three months to 2026-06-30$3.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-14, accession 0001654954-26-007657.Report this figure
Operating income$k(7,468)Operating income, Q4 FY2023, three months to 2023-09-30−$7.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-01-13, accession 0001654954-25-000288. Derived: 12-month figure less the 9-month figure.Report this figure(6,486)Operating income, Q1 FY2024, three months to 2023-12-31−$6.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-02-14, accession 0001654954-25-001578.Report this figure(7,076)Operating income, Q2 FY2024, three months to 2024-03-31−$7.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-14, accession 0001654954-25-005606.Report this figure(6,670)Operating income, Q3 FY2024, three months to 2024-06-30−$6.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0001654954-25-009568.Report this figure(6,120)Operating income, Q4 FY2024, three months to 2024-09-30−$6.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-12-29, accession 0001654954-25-014303. Derived: 12-month figure less the 9-month figure.Report this figure(6,893)Operating income, Q1 FY2025, three months to 2024-12-31−$6.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-17, accession 0001654954-26-001319.Report this figure(6,394)Operating income, Q2 FY2025, three months to 2025-03-31−$6.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001654954-26-005005.Report this figure(5,489)Operating income, Q3 FY2025, three months to 2025-06-30−$5.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001654954-26-007657.Report this figure(6,033)Operating income, Q4 FY2025, three months to 2025-09-30−$6.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-12-29, accession 0001654954-25-014303. Derived: 12-month figure less the 9-month figure.Report this figure(5,369)Operating income, Q1 FY2026, three months to 2025-12-31−$5.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-17, accession 0001654954-26-001319.Report this figure(5,326)Operating income, Q2 FY2026, three months to 2026-03-31−$5.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001654954-26-005005.Report this figure(5,557)Operating income, Q3 FY2026, three months to 2026-06-30−$5.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001654954-26-007657.Report this figure
Interest expense$knot reportednot reportednot reportednot reportednot reported170Interest expense, Q1 FY2025, three months to 2024-12-31$170.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-02-17, accession 0001654954-26-001319.Report this figure178Interest expense, Q2 FY2025, three months to 2025-03-31$178.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-15, accession 0001654954-26-005005.Report this figure172Interest expense, Q3 FY2025, three months to 2025-06-30$172.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-14, accession 0001654954-26-007657.Report this figure129Interest expense, Q4 FY2025, three months to 2025-09-30$129.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2025-12-29, accession 0001654954-25-014303. Derived: 12-month figure less the 9-month figure.Report this figure88.0Interest expense, Q1 FY2026, three months to 2025-12-31$88.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-02-17, accession 0001654954-26-001319.Report this figure117Interest expense, Q2 FY2026, three months to 2026-03-31$117.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-15, accession 0001654954-26-005005.Report this figure111Interest expense, Q3 FY2026, three months to 2026-06-30$111.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-14, accession 0001654954-26-007657.Report this figure
Income tax$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$k(7,802)Net income, Q4 FY2023, three months to 2023-09-30−$7.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-01-13, accession 0001654954-25-000288. Derived: 12-month figure less the 9-month figure.Report this figure(6,710)Net income, Q1 FY2024, three months to 2023-12-31−$6.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-14, accession 0001654954-25-009568.Report this figure(7,245)Net income, Q2 FY2024, three months to 2024-03-31−$7.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-14, accession 0001654954-25-009568.Report this figure(6,857)Net income, Q3 FY2024, three months to 2024-06-30−$6.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-14, accession 0001654954-25-009568.Report this figure(6,109)Net income, Q4 FY2024, three months to 2024-09-30−$6.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-12-29, accession 0001654954-25-014303. Derived: 12-month figure less the 9-month figure.Report this figure(7,073)Net income, Q1 FY2025, three months to 2024-12-31−$7.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001654954-26-007657.Report this figure(6,572)Net income, Q2 FY2025, three months to 2025-03-31−$6.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001654954-26-007657.Report this figure(5,665)Net income, Q3 FY2025, three months to 2025-06-30−$5.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001654954-26-007657.Report this figure(6,101)Net income, Q4 FY2025, three months to 2025-09-30−$6.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-12-29, accession 0001654954-25-014303. Derived: 12-month figure less the 9-month figure.Report this figure(5,469)Net income, Q1 FY2026, three months to 2025-12-31−$5.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001654954-26-007657.Report this figure(5,466)Net income, Q2 FY2026, three months to 2026-03-31−$5.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001654954-26-007657.Report this figure(5,668)Net income, Q3 FY2026, three months to 2026-06-30−$5.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001654954-26-007657.Report this figure
Diluted EPS$ per sharenot reported(0.14)Diluted EPS, Q1 FY2024, three months to 2023-12-31−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-02-14, accession 0001654954-25-001578.Report this figure(0.14)Diluted EPS, Q2 FY2024, three months to 2024-03-31−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-14, accession 0001654954-25-005606.Report this figure(4.18)Diluted EPS, Q3 FY2024, three months to 2024-06-30−$4.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0001654954-25-009568.Report this figurenot reported(3.25)Diluted EPS, Q1 FY2025, three months to 2024-12-31−$3.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-17, accession 0001654954-26-001319.Report this figure(2.33)Diluted EPS, Q2 FY2025, three months to 2025-03-31−$2.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001654954-26-005005.Report this figure(1.36)Diluted EPS, Q3 FY2025, three months to 2025-06-30−$1.36 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001654954-26-007657.Report this figurenot reported(0.68)Diluted EPS, Q1 FY2026, three months to 2025-12-31−$0.68 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-17, accession 0001654954-26-001319.Report this figure(0.67)Diluted EPS, Q2 FY2026, three months to 2026-03-31−$0.67 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001654954-26-005005.Report this figure(0.47)Diluted EPS, Q3 FY2026, three months to 2026-06-30−$0.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001654954-26-007657.Report this figure
Basic EPS$ per sharenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Balance sheet

Shareholders' equity$11.0m, Q3 FY2026
CEL Sci Corp, balance sheet, quarterly
Line itemUnitFY20232023-09-30Q1 FY20242023-12-31Q2 FY20242024-03-31Q3 FY20242024-06-30FY20242024-09-30Q1 FY20252024-12-31Q2 FY20252025-03-31Q3 FY20252025-06-30FY20252025-09-30Q1 FY20262025-12-31Q2 FY20262026-03-31Q3 FY20262026-06-30
Cash and equivalents$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current assets$m6.9Current assets, FY2023, at 2023-09-30$6.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-01-13, accession 0001654954-25-000288.Report this figure6.2Current assets, Q1 FY2024, at 2023-12-31$6.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-02-14, accession 0001654954-24-001793.Report this figure8.5Current assets, Q2 FY2024, at 2024-03-31$8.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-15, accession 0001654954-24-006411.Report this figure3.5Current assets, Q3 FY2024, at 2024-06-30$3.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-14, accession 0001654954-24-010651.Report this figure6.1Current assets, FY2024, at 2024-09-30$6.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-12-29, accession 0001654954-25-014303.Report this figure5.9Current assets, Q1 FY2025, at 2024-12-31$5.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-02-14, accession 0001654954-25-001578.Report this figure3.0Current assets, Q2 FY2025, at 2025-03-31$3.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0001654954-25-005606.Report this figure2.6Current assets, Q3 FY2025, at 2025-06-30$2.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0001654954-25-009568.Report this figure11.6Current assets, FY2025, at 2025-09-30$11.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-14, accession 0001654954-26-007657.Report this figure7.0Current assets, Q1 FY2026, at 2025-12-31$7.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-02-17, accession 0001654954-26-001319.Report this figure2.9Current assets, Q2 FY2026, at 2026-03-31$2.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-15, accession 0001654954-26-005005.Report this figure7.5Current assets, Q3 FY2026, at 2026-06-30$7.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-14, accession 0001654954-26-007657.Report this figure
Total assets$m30.5Total assets, FY2023, at 2023-09-30$30.5m. XBRL concept us-gaap:Assets. 10-K filed 2025-01-13, accession 0001654954-25-000288.Report this figure28.7Total assets, Q1 FY2024, at 2023-12-31$28.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-02-14, accession 0001654954-24-001793.Report this figure30.0Total assets, Q2 FY2024, at 2024-03-31$30.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-15, accession 0001654954-24-006411.Report this figure24.1Total assets, Q3 FY2024, at 2024-06-30$24.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0001654954-24-010651.Report this figure27.0Total assets, FY2024, at 2024-09-30$27.0m. XBRL concept us-gaap:Assets. 10-K filed 2025-12-29, accession 0001654954-25-014303.Report this figure25.7Total assets, Q1 FY2025, at 2024-12-31$25.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-02-14, accession 0001654954-25-001578.Report this figure21.8Total assets, Q2 FY2025, at 2025-03-31$21.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0001654954-25-005606.Report this figure20.3Total assets, Q3 FY2025, at 2025-06-30$20.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0001654954-25-009568.Report this figure28.2Total assets, FY2025, at 2025-09-30$28.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001654954-26-007657.Report this figure22.9Total assets, Q1 FY2026, at 2025-12-31$22.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-02-17, accession 0001654954-26-001319.Report this figure17.7Total assets, Q2 FY2026, at 2026-03-31$17.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-15, accession 0001654954-26-005005.Report this figure21.4Total assets, Q3 FY2026, at 2026-06-30$21.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001654954-26-007657.Report this figure
Current liabilities$m5.6Current liabilities, FY2023, at 2023-09-30$5.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-01-13, accession 0001654954-25-000288.Report this figure4.9Current liabilities, Q1 FY2024, at 2023-12-31$4.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-02-14, accession 0001654954-24-001793.Report this figure5.1Current liabilities, Q2 FY2024, at 2024-03-31$5.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-15, accession 0001654954-24-006411.Report this figure5.5Current liabilities, Q3 FY2024, at 2024-06-30$5.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0001654954-24-010651.Report this figure4.6Current liabilities, FY2024, at 2024-09-30$4.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-12-29, accession 0001654954-25-014303.Report this figure5.5Current liabilities, Q1 FY2025, at 2024-12-31$5.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-02-14, accession 0001654954-25-001578.Report this figure5.5Current liabilities, Q2 FY2025, at 2025-03-31$5.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-14, accession 0001654954-25-005606.Report this figure5.6Current liabilities, Q3 FY2025, at 2025-06-30$5.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0001654954-25-009568.Report this figure5.1Current liabilities, FY2025, at 2025-09-30$5.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001654954-26-007657.Report this figure5.0Current liabilities, Q1 FY2026, at 2025-12-31$5.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-02-17, accession 0001654954-26-001319.Report this figure4.8Current liabilities, Q2 FY2026, at 2026-03-31$4.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-15, accession 0001654954-26-005005.Report this figure5.1Current liabilities, Q3 FY2026, at 2026-06-30$5.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001654954-26-007657.Report this figure
Total liabilities$m17.3Total liabilities, FY2023, at 2023-09-30$17.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-01-13, accession 0001654954-25-000288.Report this figure16.1Total liabilities, Q1 FY2024, at 2023-12-31$16.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-02-14, accession 0001654954-24-001793.Report this figure15.7Total liabilities, Q2 FY2024, at 2024-03-31$15.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-15, accession 0001654954-24-006411.Report this figure15.6Total liabilities, Q3 FY2024, at 2024-06-30$15.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-14, accession 0001654954-24-010651.Report this figure14.1Total liabilities, FY2024, at 2024-09-30$14.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-12-29, accession 0001654954-25-014303.Report this figure14.4Total liabilities, Q1 FY2025, at 2024-12-31$14.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-02-14, accession 0001654954-25-001578.Report this figure13.8Total liabilities, Q2 FY2025, at 2025-03-31$13.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-14, accession 0001654954-25-005606.Report this figure13.3Total liabilities, Q3 FY2025, at 2025-06-30$13.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0001654954-25-009568.Report this figure12.2Total liabilities, FY2025, at 2025-09-30$12.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001654954-26-007657.Report this figure11.8Total liabilities, Q1 FY2026, at 2025-12-31$11.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-02-17, accession 0001654954-26-001319.Report this figure10.8Total liabilities, Q2 FY2026, at 2026-03-31$10.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-15, accession 0001654954-26-005005.Report this figure10.4Total liabilities, Q3 FY2026, at 2026-06-30$10.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001654954-26-007657.Report this figure
Shareholders' equity$m13.2Shareholders' equity, FY2023, at 2023-09-30$13.2m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-12-29, accession 0001654954-25-014303.Report this figure12.7Shareholders' equity, Q1 FY2024, at 2023-12-31$12.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-14, accession 0001654954-25-009568.Report this figure14.3Shareholders' equity, Q2 FY2024, at 2024-03-31$14.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-14, accession 0001654954-25-009568.Report this figure8.5Shareholders' equity, Q3 FY2024, at 2024-06-30$8.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-14, accession 0001654954-25-009568.Report this figure12.9Shareholders' equity, FY2024, at 2024-09-30$12.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001654954-26-007657.Report this figure11.3Shareholders' equity, Q1 FY2025, at 2024-12-31$11.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001654954-26-007657.Report this figure8.0Shareholders' equity, Q2 FY2025, at 2025-03-31$8.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001654954-26-007657.Report this figure7.0Shareholders' equity, Q3 FY2025, at 2025-06-30$7.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001654954-26-007657.Report this figure16.0Shareholders' equity, FY2025, at 2025-09-30$16.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001654954-26-007657.Report this figure11.1Shareholders' equity, Q1 FY2026, at 2025-12-31$11.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001654954-26-007657.Report this figure6.9Shareholders' equity, Q2 FY2026, at 2026-03-31$6.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001654954-26-007657.Report this figure11.0Shareholders' equity, Q3 FY2026, at 2026-06-30$11.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001654954-26-007657.Report this figure

Cash flow

Operating cash flow−$4.0m, Q3 FY2026
Capital expenditure$0, Q3 FY2026
CEL Sci Corp, cash flow, quarterly
Line itemUnitQ4 FY20232023-09-30Q1 FY20242023-12-31Q2 FY20242024-03-31Q3 FY20242024-06-30Q4 FY20242024-09-30Q1 FY20252024-12-31Q2 FY20252025-03-31Q3 FY20252025-06-30Q4 FY20252025-09-30Q1 FY20262025-12-31Q2 FY20262026-03-31Q3 FY20262026-06-30
Operating cash flow$k(5,045)Operating cash flow, Q4 FY2023, three months to 2023-09-30−$5.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-01-13, accession 0001654954-25-000288. Derived: 12-month figure less the 9-month figure.Report this figure(4,888)Operating cash flow, Q1 FY2024, three months to 2023-12-31−$4.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-02-14, accession 0001654954-25-001578.Report this figure(4,528)Operating cash flow, Q2 FY2024, three months to 2024-03-31−$4.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0001654954-25-005606. Derived: 6-month figure less the 3-month figure.Report this figure(4,579)Operating cash flow, Q3 FY2024, three months to 2024-06-30−$4.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0001654954-25-009568. Derived: 9-month figure less the 6-month figure.Report this figure(4,817)Operating cash flow, Q4 FY2024, three months to 2024-09-30−$4.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-12-29, accession 0001654954-25-014303. Derived: 12-month figure less the 9-month figure.Report this figure(4,140)Operating cash flow, Q1 FY2025, three months to 2024-12-31−$4.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-17, accession 0001654954-26-001319.Report this figure(4,370)Operating cash flow, Q2 FY2025, three months to 2025-03-31−$4.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001654954-26-005005. Derived: 6-month figure less the 3-month figure.Report this figure(3,940)Operating cash flow, Q3 FY2025, three months to 2025-06-30−$3.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001654954-26-007657. Derived: 9-month figure less the 6-month figure.Report this figure(4,671)Operating cash flow, Q4 FY2025, three months to 2025-09-30−$4.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-12-29, accession 0001654954-25-014303. Derived: 12-month figure less the 9-month figure.Report this figure(4,022)Operating cash flow, Q1 FY2026, three months to 2025-12-31−$4.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-17, accession 0001654954-26-001319.Report this figure(4,022)Operating cash flow, Q2 FY2026, three months to 2026-03-31−$4.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001654954-26-005005. Derived: 6-month figure less the 3-month figure.Report this figure(4,031)Operating cash flow, Q3 FY2026, three months to 2026-06-30−$4.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001654954-26-007657. Derived: 9-month figure less the 6-month figure.Report this figure
Capital expenditure$k0.0Capital expenditure, Q4 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-01-13, accession 0001654954-25-000288. Derived: 12-month figure less the 9-month figure.Report this figure51.7Capital expenditure, Q1 FY2024, three months to 2023-12-31$51.6k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-02-14, accession 0001654954-25-001578.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-14, accession 0001654954-25-005606. Derived: 6-month figure less the 3-month figure.Report this figure23.5Capital expenditure, Q3 FY2024, three months to 2024-06-30$23.5k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-14, accession 0001654954-25-009568. Derived: 9-month figure less the 6-month figure.Report this figure19.8Capital expenditure, Q4 FY2024, three months to 2024-09-30$19.8k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-12-29, accession 0001654954-25-014303. Derived: 12-month figure less the 9-month figure.Report this figure33.0Capital expenditure, Q1 FY2025, three months to 2024-12-31$33.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-17, accession 0001654954-26-001319.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-15, accession 0001654954-26-005005. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-14, accession 0001654954-26-007657. Derived: 9-month figure less the 6-month figure.Report this figure5.2Capital expenditure, Q4 FY2025, three months to 2025-09-30$5.2k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-12-29, accession 0001654954-25-014303. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-17, accession 0001654954-26-001319.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-15, accession 0001654954-26-005005. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-14, accession 0001654954-26-007657. Derived: 9-month figure less the 6-month figure.Report this figure

Shares

Diluted shares (weighted)12.12m, Q3 FY2026
CEL Sci Corp, shares, quarterly
Line itemUnitQ1 FY20222021-12-31Q3 FY20222022-06-30Q1 FY20232022-12-31Q1 FY20242023-12-31Q2 FY20242024-03-31Q3 FY20242024-06-30Q1 FY20252024-12-31Q2 FY20252025-03-31Q3 FY20252025-06-30Q1 FY20262025-12-31Q2 FY20262026-03-31Q3 FY20262026-06-30
Diluted shares (weighted)m shares43.1Diluted shares (weighted), Q1 FY2022, three months to 2021-12-3143,083,420 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-02-14, accession 0001654954-23-001725.Report this figure43.2Diluted shares (weighted), Q3 FY2022, three months to 2022-06-3043,174,775 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2022-08-12, accession 0001654954-22-011196.Report this figure44.4Diluted shares (weighted), Q1 FY2023, three months to 2022-12-3144,440,387 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-02-14, accession 0001654954-23-001725.Report this figure48.5Diluted shares (weighted), Q1 FY2024, three months to 2023-12-3148,470,600 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-02-14, accession 0001654954-25-001578.Report this figure52.0Diluted shares (weighted), Q2 FY2024, three months to 2024-03-3152,006,442 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-14, accession 0001654954-25-005606.Report this figure1.8Diluted shares (weighted), Q3 FY2024, three months to 2024-06-301,799,813 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0001654954-25-009568.Report this figure2.2Diluted shares (weighted), Q1 FY2025, three months to 2024-12-312,177,529 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-02-17, accession 0001654954-26-001319.Report this figure2.8Diluted shares (weighted), Q2 FY2025, three months to 2025-03-312,818,004 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001654954-26-005005.Report this figure4.2Diluted shares (weighted), Q3 FY2025, three months to 2025-06-304,150,702 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-14, accession 0001654954-26-007657.Report this figure8.0Diluted shares (weighted), Q1 FY2026, three months to 2025-12-318,015,739 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-02-17, accession 0001654954-26-001319.Report this figure8.1Diluted shares (weighted), Q2 FY2026, three months to 2026-03-318,138,233 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001654954-26-005005.Report this figure12.1Diluted shares (weighted), Q3 FY2026, three months to 2026-06-3012,116,390 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-14, accession 0001654954-26-007657.Report this figure

Shares outstanding: 17.59mShares outstanding, period not labelled, at 2026-08-1017,588,987 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-14, accession 0001654954-26-007657.Report this figure at Aug 10, 2026, from the cover of the 10-Q filed Aug 14, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. Listed shows no prices and gives no investment advice.